7 research outputs found
Quantitative MALDI mass spectrometry imaging for exploring cutaneous drug delivery of tofacitinib in human skin
In skin penetration studies, HPLC-MS/MS analysis on extracts of heat-separated epidermis and dermis provides an estimate of the amount of drug penetrated. In this study, MALDI-MSI enabled qualitative skin distribution analysis of endogenous molecules and the drug molecule, tofacitinib and quantitative analysis of the amount of tofacitinib in the epidermis. The delivery of tofacitinib to the skin was investigated in a Franz diffusion cell using three different formulations (two oil-in-water creams, C1 and C2 and an aqueous gel). Further, in vitro release testing (IVRT) was performed and resulted in the fastest release of tofacitinib from the aqueous gel and the lowest from C2. In the ex vivo skin penetration and permeation study, C1 showed the largest skin retention of tofacitinib, whereas, lower retention and higher permeation were observed for the gel and C2. The quantitative MALDI-MSI analysis showed that the content of tofacitinib in the epidermis for the C1 treated samples was comparable to HPLC-MS/MS analysis, whereas, the samples treated with C2 and the aqueous gel were below LOQ. The study demonstrates that MALDI-MSI can be used for the quantitative determination of drug penetration in epidermis, as well as, to provide valuable information on qualitative skin distribution of tofacitinib
Solubility Prediction of Different Forms of Pharmaceuticals in Single and Mixed Solvents Using Symmetric Electrolyte Nonrandom Two-Liquid Segment Activity Coefficient Model
An
improved framework has been developed for solubility prediction
of different forms of a medium-sized antibiotic (i.e., nonelectrolyte,
electrolyte, and solvate) in single and mixed solvents using a symmetrically
reformulated electrolyte nonrandom two-liquid segment activity coefficient
(eNRTL-SAC) model. The methodology incorporates key features of the
symmetric eNRTL-SAC model structure to reduce the number of parameters
and uses a hybrid of global search algorithms for parameter estimation.
Moreover, a design of experiments is included in the methodology to
generate and use experimental data appropriately for model parameter
regression and model validation. Because of the semipredictive nature
of the symmetric eNRTL-SAC model, the segment parameter regression
is a critical step for solubility prediction accuracy. A particle
swarm optimization algorithm is incorporated to preregress conceptual
segment parameters of solutes. The preregressed segment parameters
were used as initial guesses for further segment parameter estimation.
In this way, consistent segment parameters that reflect the characteristics
of solutes in solution were estimated. The methodology application
is demonstrated by predicting the solubility of fusidic acid, sodium
fusidate, and fusidic acid acetone solvate in single and mixed solvents
as well as at different temperature. The solubility predictions of
fusidic acid, fusidic acid acetone solvate, and sodium fusidate in
various single solvents show good agreement with experimental solubility
with average squared relative errors of 0.055, 0.079, and 0.084 in
logarithmic mole fraction scale, respectively. The model moreover
predicts solubilities in binary solvent mixture and as a function
of temperature in satisfactory agreement with experimental solubility
Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients
<p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13555-016-0125-6">https://link.springer.com/article/10.1007/s13555-016-0125-6</a></p><p></p>
<p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âÂÂmailto:[email protected]âÂÂ"><b>[email protected]</b></a>.</p>
<p><br></p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as âpeer reviewedâ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>⢠Slide decks</p>
<p>⢠Videos and animations</p>
<p>⢠Audio abstracts</p>
<p>⢠Audio slides</p